Edit
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Continuous Bioprocessing Market to reach USD 636.91 million by the end of 2030.

Global Continuous Bioprocessing Market Size study & Forecast, by Product (Filtration Systems and Consumables, Chromatography Systems and Consumables, Bioreactors, Sterilizers, Centrifuges, Others), by Application (Commercial, Vaccines, mAb production, Recombinant Protein Production, Cell and Gene Therapy Production, R&D), by End User and Regional Analysis, 2023-2030

Product Code: HLSB-23531543
Publish Date: 20-12-2023
Page: 200

Global Continuous Bioprocessing Market is valued at approximately USD 125.6 million in 2022 and is anticipated to grow with a healthy growth rate of more than 22.50% during the forecast period 2023-2030. Continuous bioprocessing refers to a method of manufacturing in the biopharmaceutical industry where the production steps for biological products occur without interruption, as opposed to traditional batch processing. The Continuous Bioprocessing Market is expanding because of factors such as the increasing number of contract development and manufacturing organizations and the rising demand for biopharmaceuticals. In a continuous bioprocessing setup, various stages of the production process, such as cell culture, harvest, purification, and formulation, are connected in a continuous flow rather than being conducted as separate, distinct batches. As a result, the demand for Continuous Bioprocessing has progressively increased in the international market during the forecast period 2023-2030.

Continuous bioprocessing has the potential to reduce overall manufacturing costs by improving resource utilization, minimizing downtime, and optimizing production processes. CDMOs, as service providers, are often focused on delivering cost-effective solutions to their clients. According to Statista, the Contract Development and Manufacturing Organization (CDMO) market accounted for USD 115.5 billion in 2020 and is projected to reach up to USD 223.5 billion by the year 2030. Another important factor that drives the Continuous Bioprocessing Market is the increasing demand for biopharmaceuticals. Continuous bioprocessing can contribute to improved product quality and consistency. Real-time monitoring and control mechanisms enhance the ability to maintain desired product attributes, reducing variability and ensuring high-quality biopharmaceuticals. In addition, as per Statista, the global pharmaceutical market accounted for USD 1.48 trillion in 2022. This represents a marginal gain from 2021 when the market was valued at USD 1.42 trillion. Moreover, the increasing number of contract development and manufacturing organizations and rising demand for biopharmaceuticals are anticipated to create lucrative growth opportunities for the market over the forecast period. However, high capital investments and stringent regulatory requirements are going to impede overall market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Continuous Bioprocessing Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the biopharmaceutical companies forming strategic partnerships and collaborations to expand their market presence in the region. The region’s dominant performance is anticipated to propel the overall demand for Continuous Bioprocessing. Furthermore, Asia Pacific is expected to grow fastest over the forecast period, owing to factors such as bioprocessing technology and partnership expansions, as well as collaborations with key players in biopharma manufacturing in the region.

Major market player included in this report are:
3M Company
Danaher Corporation
Thermo Fisher Scientific, Inc
Merck KGaA
Sartorius AG
Repligen Corporation
Eppendorf SE
Applikon Biotechnology B.V.
Pall Corporation
Bionet Co., Ltd

Recent Developments in the Market:
Ø In May 2023, 3M has allocated USD 146 million for the enhancement of its biopharma filtration technology. This substantial investment to be directed towards facility enhancements, equipment upgrades, and the recruitment of 60 full-time manufacturing employees in Europe. 3M’s cutting-edge filter technology plays a crucial role in bioprocessing, biological, and small molecule pharmaceutical manufacturing. Specifically designed for customers involved in the production of biopharmaceutical drugs, these filters are instrumental in capturing impurities, ensuring the quality and purity of the pharmaceutical products.

Global Continuous Bioprocessing Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Product, Application, End User, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product
Filtration Systems and Consumables
Chromatography Systems and Consumables
Bioreactors
Sterilizers
Centrifuges
Others

By Application
Commercial
Vaccines
mAb production
Recombinant Protein Production
Cell and Gene Therapy Production
R&D

By End User
Contract Development and Manufacturing Organizations and Contract Research Organizations
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Continuous Bioprocessing Market, by Region, 2020-2030 (USD Million)
1.2.2. Continuous Bioprocessing Market, by Product, 2020-2030 (USD Million)
1.2.3. Continuous Bioprocessing Market, by Application, 2020-2030 (USD Million)
1.2.4. Continuous Bioprocessing Market, by End User, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Continuous Bioprocessing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Continuous Bioprocessing Market Dynamics
3.1. Continuous Bioprocessing Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing number of contract development and manufacturing organizations
3.1.1.2. Rising demand for biopharmaceuticals
3.1.2. Market Challenges
3.1.2.1. High capital investments
3.1.2.2. Stringent regulatory requirements
3.1.3. Market Opportunities
3.1.3.1. Rising emergence of integrated end-to-end continuous bioprocessing
3.1.3.2. Supportive government initiatives towards innovative technologies in continuous bioprocessing
Chapter 4. Global Continuous Bioprocessing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Continuous Bioprocessing Market, by Product
5.1. Market Snapshot
5.2. Global Continuous Bioprocessing Market by Product, Performance – Potential Analysis
5.3. Global Continuous Bioprocessing Market Estimates & Forecasts by Product 2020-2030 (USD Million)
5.4. Continuous Bioprocessing Market, Sub Segment Analysis
5.4.1. Filtration Systems and Consumables
5.4.2. Chromatography Systems and Consumables
5.4.3. Bioreactors
5.4.4. Sterilizers
5.4.5. Centrifuges
5.4.6. Others
Chapter 6. Global Continuous Bioprocessing Market, by Application
6.1. Market Snapshot
6.2. Global Continuous Bioprocessing Market by Application, Performance – Potential Analysis
6.3. Global Continuous Bioprocessing Market Estimates & Forecasts by Application 2020-2030 (USD Million)
6.4. Continuous Bioprocessing Market, Sub Segment Analysis
6.4.1. Commercial
6.4.2. Vaccines
6.4.3. mAb production
6.4.4. Recombinant Protein Production
6.4.5. Cell and Gene Therapy Production
6.4.6. R&D
Chapter 7. Global Continuous Bioprocessing Market, by End User
7.1. Market Snapshot
7.2. Global Continuous Bioprocessing Market by End User, Performance – Potential Analysis
7.3. Global Continuous Bioprocessing Market Estimates & Forecasts by End User 2020-2030 (USD Million)
7.4. Continuous Bioprocessing Market, Sub Segment Analysis
7.4.1. Contract Development and Manufacturing Organizations and Contract Research Organizations
7.4.2. Pharmaceutical and Biotechnology Companies
7.4.3. Academic and Research Institutes
Chapter 8. Global Continuous Bioprocessing Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Continuous Bioprocessing Market, Regional Market Snapshot
8.4. North America Continuous Bioprocessing Market
8.4.1. U.S. Continuous Bioprocessing Market
8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Continuous Bioprocessing Market
8.5. Europe Continuous Bioprocessing Market Snapshot
8.5.1. U.K. Continuous Bioprocessing Market
8.5.2. Germany Continuous Bioprocessing Market
8.5.3. France Continuous Bioprocessing Market
8.5.4. Spain Continuous Bioprocessing Market
8.5.5. Italy Continuous Bioprocessing Market
8.5.6. Rest of Europe Continuous Bioprocessing Market
8.6. Asia-Pacific Continuous Bioprocessing Market Snapshot
8.6.1. China Continuous Bioprocessing Market
8.6.2. India Continuous Bioprocessing Market
8.6.3. Japan Continuous Bioprocessing Market
8.6.4. Australia Continuous Bioprocessing Market
8.6.5. South Korea Continuous Bioprocessing Market
8.6.6. Rest of Asia Pacific Continuous Bioprocessing Market
8.7. Latin America Continuous Bioprocessing Market Snapshot
8.7.1. Brazil Continuous Bioprocessing Market
8.7.2. Mexico Continuous Bioprocessing Market
8.8. Middle East & Africa Continuous Bioprocessing Market
8.8.1. Saudi Arabia Continuous Bioprocessing Market
8.8.2. South Africa Continuous Bioprocessing Market
8.8.3. Rest of Middle East & Africa Continuous Bioprocessing Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. 3M Company
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Danaher Corporation
9.3.3. Thermo Fisher Scientific, Inc
9.3.4. Merck KGaA
9.3.5. Sartorius AG
9.3.6. Repligen Corporation
9.3.7. Eppendorf SE
9.3.8. Applikon Biotechnology B.V.
9.3.9. Pall Corporation
9.3.10. Bionet Co., Ltd
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now